ArticleChemSusChem2026
An Unorthodox Enolate-Triggered Radical Relay Directs the Chemo Upgrading of Levulinic Acid Into Citramalic Acid.
Article in ChemSusChem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
We report a transition-metal-free and highly selective chemical transformation of levulinic acid into citramalic acid via t-butoxide-mediated enolate chemistry, complementing both the biotransformation of glucose and glycerol using E. coli as well as transition-metal-catalyzed processes based on levulinic acid. The atypical behavior of t-butoxide-classically recognized as a base that favors kinetic enolate formation in carbonyl chemistry-proves crucial for accessing the thermodynamic enolate under elevated temperatures and extended reaction times, thereby directing the reaction toward citramalic acid as the major product. Radical-trapping experiments with TEMPO (2,2,6,6-tetramethylpiperidine 1-oxyl) and benzoic acid significantly diminished the product yield, indicating the involvement of radical intermediates in the initial oxygenation sequence and providing clear mechanistic insight into the operative pathway. Moreover, citramalic acid serves as a sustainable, bio-based platform chemical that is amenable to downstream valorization into high-value feedstocks, such as unnatural amino acid derivative and itaconic acid.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.